RNhale GmbH is a spin-off originating from the Ludwig-Maximilians-University Munich, aiming to revolutionize the pharmaceutical landscape by developing a unique platform technology for formulating RNA-loaded lipid nanoparticles (LNPs) as an inhalable dry powder. This disruptive approach synergizes technological and pharmaceutical strategies to create a novel therapeutic formulation with significant advantages over common LNP-RNA delivery methods. The target is pulmonary diseases with vast addressable markets and undeniable medical needs.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Munich, Bavaria, De
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.RNhale.com
- HQ
- Munich, Bavaria
Rnhale Questions
Rnhale's website is http://www.RNhale.com
Rnhale's LinkedIn profile is https://de.linkedin.com/company/rnhale
Rnhale has
7 employees.
View email and phone details for 7
employees at Rnhale.
Rnhale's industry is
Pharmaceutical Manufacturing
Rnhale's categories are Pharmaceutical Manufacturing
Rnhale's founding year is 2023
